| Serial Number | 98606322 |
| Word Mark | OXB |
| Filing Date | Tuesday, June 18, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, March 19, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Custom and contract manufacture of products relating to biotechnology, namely, gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products, viral and non-viral vectors, and vaccines |
| Description of Mark | The mark consists of the letters "OXB". The top right of the letter "X" is connected to the top left of the letter "B". A double helix design is to the right of the letters "OXB". |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Biotechnology research and laboratory analytic and diagnostic services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; design of biotechnology manufacturing facilities; quality control and validation services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector and analytic assay development for others; laboratory services for biomanufacturing; research and development services for bio-manufacturing; genetic engineering laboratories and biochemistry laboratories; scientific and technological services and research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; industrial analysis services in the field of biotechnology; provision of information relating to scientific research; providing scientific information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; research and scientific analysis relating to drug discovery and development for others; scientific research and technology advisory services; scientific research and technology consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; providing scientific information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; advisory services relating to scientific and clinical research; biological research; providing clinical and medical research information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; clinical research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; Scientific research in the nature of conducting clinical trials for others; bio-manufacturing development services |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 18, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 18, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Oxford BioMedica plc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 84 - NOT AVAILABLE |
| Address | Oxford OX46LT GB |
| Event Date | Event Description |
| Tuesday, June 18, 2024 | NEW APPLICATION ENTERED |
| Sunday, January 12, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sunday, January 12, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 13, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, March 18, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 18, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 19, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 24, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, January 24, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, January 24, 2025 | NON-FINAL ACTION E-MAILED |